Separately, Zacks Investment Research upgraded shares of NOVOZYMES A/S/S from a sell rating to a hold rating in a report on Saturday, August 10th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus price target of $54.00.
Shares of OTCMKTS NVZMY opened at $40.71 on Monday. The company’s fifty day moving average is $45.30 and its 200-day moving average is $46.22. The stock has a market cap of $12.32 billion, a price-to-earnings ratio of 23.26, a P/E/G ratio of 1.94 and a beta of 0.70. NOVOZYMES A/S/S has a twelve month low of $40.38 and a twelve month high of $55.84. The company has a quick ratio of 0.71, a current ratio of 1.22 and a debt-to-equity ratio of 0.05.
Novozymes A/S produces and sells industrial enzymes and microorganisms worldwide. The company offers agriculture solutions, including crop protection, and animal health and nutrition solutions; fermentation, lignecellulosic hydrolysis, liquefaction, process enhancement, and saccharifaction solutions for bioenergy; baking, beverages, dairy, and protein ingredients for the food and beverage industry; and laundry, dishwashing, hand washing, and cleaning solutions for the household care industry.
Featured Article: Why is the ex-dividend date different from the record date?
Receive News & Ratings for NOVOZYMES A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NOVOZYMES A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.